Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare today announced the opening of its new technology facility at the Science for Life Laboratory (SciLifeLab) in Stockholm, Sweden.

The lab is furnished with GE's tools and technologies for protein, cell biology, and biomedical research and intends to collaborate with SciLifeLab researchers in human disease. A full-time GE manager and two technical specialists will staff the lab.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.